REGENERON PHARMACEUTICALS, INC. — 13F Holdings

2026 Q1  ·  2 Positions

2026 Q1 Portfolio Activity

In 2026 Q1, REGENERON PHARMACEUTICALS, INC. maintained a portfolio of 2 distinct positions.
Position History hover any row below to update
Loading…
REGENERON PHARMACEUTICALS, INC. Tarrytown, NY Operating Company AUM $48M
Fund Overview SEC EDGAR
PCA Score Concentration Risk
Risk ENB
To Excel To CSV
Total Positions
2
Quarter
2026 Q1
Top Holding
NTLA (99.1%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-2 of 2
Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
NTLA
Intellia Therap...
Healthcare 99.14% 98.49% #1
Prev: #1
7.0
—
no change no change
P
S
3,702,995 $47,472,396
$11.66 +12.6%
$12.82 +2.4%
2024 Q4 13F Filing 2026-03-31 2026-05-08
ACET
Adicet Bio, Inc...
Healthcare 0.86% 1.51% #2
Prev: #2
2.8
—
no change no change
P
S
60,511 $412,080 2024 Q4 13F Filing 2026-03-31 2026-05-08
Showing 1-2 of 2 holdings

Unlock Full REGENERON PHARMACEUTICALS, INC. Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Upgrade to PRO
Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →